Experimental confirmation of global murine cytomegalovirus open reading frames by transcriptional detection and partial characterization of newly described gene products

Journal of Virology

Volumn 80, Issue 14, 2006, Pages 6873-6882

  Tang, Qiyi ^a   Murphy, Eain A ^b   Maul, Gerd G ^a  

^a WISTAR INSTITUTE   (United States)

^b PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; GENOMIC DNA;

ANIMAL CELL; ARTICLE; CELL NUCLEUS; CELL STRAIN 3T3; CYTOMEGALOVIRUS; DNA MICROARRAY; DNA SEQUENCE; FIBROBLAST; GENETIC TRANSCRIPTION; HUMAN CYTOMEGALOVIRUS; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; MITOCHONDRION; MOUSE; MURINE CYTOMEGALOVIRUS; NONHUMAN; OPEN READING FRAME; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SITE DIRECTED MUTAGENESIS;

ANIMALS; CELL NUCLEUS; CYTOMEGALOVIRUS; GENE EXPRESSION PROFILING; GENE SILENCING; GENES, VIRAL; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MITOCHONDRIA; MUROMEGALOVIRUS; NIH 3T3 CELLS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OPEN READING FRAMES; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

ANIMALIA; HUMAN HERPESVIRUS 5; MAIZE CHLOROTIC MOTTLE VIRUS; MURID HERPESVIRUS 1;

EID: 33745768154     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.00275-06     Document Type: Article

References (44)

1. Altschul, S. F., T. L. Madden, A. A. Schaffer, J. Zhang, Z. Zhang, W. Miller, and D. J. Lipman. 1997. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 25:3389-3402.
2. Arvin, A. M., P. Fast, M. Myers, S. Plotkin, and R. Rabinovich. 2004. Vaccine development to prevent cytomegalovirus disease: report from the National Vaccine Advisory Committee. Clin. Infect. Dis. 39:233-239.
3. Belzacq, A. S., C. El Hamel, H. L. Vieira, I. Cohen, D. Haouzi, D. Metivier, P. Marchetti, C. Brenner, and G. Kroemer. 2001, Adenine nucleotide translocator mediates the mitochondrial membrane permeabilization induced by lonidamine, arsenite and CD437. Oncogene 20:7579-7587.
4. Biegalke, B. J., and A. P. Geballe. 1991. Sequence requirements for activation of the HIV-1 LTR by human cytomegalovirus. Virology 183:381-385.
5. Borst, E., and M. Messerle. 2000. Development of a cytomegalovirus vector for somatic gene therapy. Bone Marrow Transplant. 2S(Suppl. 2):S80-S82.
6. Boya, P., R. A. Gonzalez-Polo, N. Casares, J. L. Perfettini, P. Dessen, N. Larochette, D. Metivier, D. Meley, S. Souquere, T. Yoshimori, G. Pierron, P. Codogno, and G. Kroemer. 2005. Inhibition of macroautophagy triggers apoptosis. Mol. Cell. Biol. 25:1025-1040.
7. Boya, P., M. C. Morales, R. A. Gonzalez-Polo, K. Andreau, I. Gourdier, J. L. Perfettini, N. Larochette, A. Deniaud, F. Baran-Marszak, R. Fagard, J. Feuillard, A. Asumendi, M. Raphael, B. Pau, C. Brenner, and G. Kroemer. 2003. The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family. Oncogene 22:6220-6230.
8. Brocchieri, L., T. N. Kledal, S. Karlin, and E. S. Mocarski. 2005. Predicting coding potential from genome sequence: application to betaherpesviruses infecting rats and mice. J. Virol. 79:7570-7596.
9. Chee, M. S., A. T. Bankier, S. Beck, R. Bohni, C. M. Brown, R. Cerny, T. Horsnell, C. A. Hutchison III, T. Kouzarides, J. A. Martignetti, et al. 1990. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Top. Microbiol. Immunol. 154:125-169.
10. Chee, M. S., S. C. Satchwell, E. Preddie, K. M. Weston, and B. G. Barrell. 1990. Human cytomegalovirus encodes three G protein-coupled receptor homologues. Nature 344:774-777.
11. Compton, T., D. M. Nowlin, and N. R Cooper. 1993. Initiation of human cytomegalovirus infection requires initial interaction with cell surface heparan sulfate. Virology 193:834-841.
12. Dargan, D. J., F. E. Jamieson, J. MacLean, A. Dolan, C. Addison, and D. J. McGeoch. 1997. The published DNA sequence of human cytomegalovirus strain AD169 lacks 929 base pairs affecting genes UL42 and UL43. J. Virol. 71:9833-9836.
13. Feire, A. L., H. Koss, and T. Compton. 2004. Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc. Natl. Acad. Sci. USA 101:15470-15475.
14. Fussey, S. P., J. R. Guest, O. F. James, M. F. Bassendine, and S. J. Yeaman. 1988. Identification and analysis of the major M2 autoantigens in primary biliary cirrhosis. Proc. Natl. Acad. Sci. USA 85:8654-8658.
15. Goldmacher, V. S., L. M. Bartle, A. Skaletskaya, C. A. Dionne, N. L. Kedersha, C. A. Vater, J. W. Han, R. J. Lutz, S. Watanabe, E. D. Cahir McFarland, E. D. Kieff, E. S. Mocarski, and T. Chittenden. 1999. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc. Natl. Acad. Sci. USA 96:12536-12541.
16. Griffiths, P. D., and S. Walter. 2005. Cytomegalovirus. Curr. Opin. Infect. Dis. 18:241-245.
17. Hanson, L. K., J. S. Slater, Z. Karabekian, G. Ciocco-Schmitt, and A. E. Campbell. 2001. Products of US22 genes M140 and M141 confer efficient replication of murine cytomegalovirus in macrophages and spleen. J. Virol. 75:6292-6302.
18. Jan, G., A. S. Belzacq, D. Haouzi, A. Rouault, D. Metivier, G. Kroemer, and C. Brenner. 2002. Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death Differ. 9:179-188.
19. Kattenhorn, L. M., R. Mills, M. Wagner, A. Lomsadze, V. Makeev, M. Borodovsky, H. L. Ploegh, and B. M. Kessler. 2004. Identification of proteins associated with murine cytomegalovirus virions. J. Virol. 78:11187-11197.
20. Lafemina, R. L., and G. S. Hayward. 1988. Differences in cell-type-specific blocks to immediate early gene expression and DNA replication of human, simian and murine cytomegalovirus. J. Gen. Virol. 69:355-374.
21. Landolfo, S., M. Gariglio, G. Gribaudo, and D. Lembo. 2003. The human cytomegalovirus. Pharmacol. Ther. 98:269-297.
22. McCormick, A. L., C. D. Meiering, G. B. Smith, and E. S. Mocarski. 2005. Mitochondrial cell death suppressors carried by human and murine cytomegalovirus confer resistance to proteasome inhibitor-induced apoptosis. J. Virol. 79:12205-12217.
23. Messerle, M., G. Hahn, W. Brune, and U. H. Koszinowski. 2000. Cytomegalovirus bacterial artificial chromosomes: a new herpesvirus vector approach. Adv. Virus Res. 55:463-478.
24. Mocarski, E. S., M. N. Prichard, C. S. Tan, and J. M. Brown. 1997. Reassessing the organization of the UL42-UL43 region of the human cytomegalovirus strain AD169 genome. Virology 239:169-175.
25. Murphy, E., I. Rigoutsos, T. Shibuya, and T. E. Shenk. 2003. Reevaluation of human cytomegalovirus coding potential. Proc. Natl. Acad. Sci. USA 100:13585-13590.
26. Murphy, E., D. Yu, J. Grimwood, J. Schmutz, M. Dickson, M. A. Jarvis, G. Hahn, J. A. Nelson, R. M. Myers, and T. E. Shenk. 2003. Coding potential of laboratory and clinical strains of human cytomegalovirus. Proc. Natl. Acad. Sci. USA 100:14976-14981.
27. Netterwald, J., S. Yang, W. Wang, S. Ghanny, M. Cody, P. Soteropoulos, B. Tian, W. Dunn, F. Liu, and H. Zhu. 2005. Two gamma interferon-activated site-like elements in the human cytomegalovirus major immediate-early promoter/enhancer are important for viral replication. J. Virol. 79:5035-5046.
28. Plotkin, S.A. 2004. Congenital cytomegalovirus infection and its prevention. Clin. Infect. Dis. 38:1038-1039.
29. Ramsay, M. E., E. Miller, and C. S. Peckham. 1991. Outcome of confirmed symptomatic congenital cytomegalovirus infection. Arch. Dis. Child. 66:1068-1069.
30. Rawlinson, W. D., H. E. Farrell, and B. G. Barrell. 1996. Analysis of the complete DNA sequence of murine cytomegalovirus. J. Virol. 70:8833-8849.
31. Roumier, T., H. L. Vieira, M. Castedo, K. F. Ferri, P. Boya, K. Andreau, S. Druillennec, N. Joza, J. M. Penninger, B. Roques, and G. Kroemer. 2002. The C-terminal moiety of HIV-1 Vpr induces cell death via a caspase-independent mitochondrial pathway. Cell Death Differ. 9:1212-1219.
32. Singh, N., C. Wannstedt, L. Keyes, M. M. Wagener, M. de Vera, T. V. Cacciarelli, and T. Gayowski. 2004. Impact of evolving trends in recipient and donor characteristics on cytomegalovirus infection in liver transplant recipients. Transplantation 77:106-110.
33. Smith, L. M., M. L. Lloyd, N. L. Harvey, A. J. Redwood, M. A. Lawson, and G. R. Shellam. 2005. Species-specificity of a murine immunocontraceptive utilising murine cytomegalovirus as a gene delivery vector. Vaccine 23:2959-2969.
34. Sweet, C. 1999. The pathogenicity of cytomegalovirus. FEMS Microbiol. Rev. 23:457-482.
35. Tang, Q., and G. G. Maul. 2003. Mouse cytomegalovirus immediate-early protein 1 binds with host cell repressors to relieve suppressive effects on viral transcription and replication during lytic infection. J. Virol. 77:1357-1367.
36. Tang, Q., and G. G. Maul. Mouse cytomegalovirus crosses the species barrier with help from a few human cytomegalovirus proteins. J. Virol., in press.
37. van den Pol, A. N., and P. K. Ghosh. 1998. Selective neuronal expression of green fluorescent protein with cytomegalovirus promoter reveals entire neuronal arbor in transgenic mice. J. Neurosci. 18:10640-10651.
38. van den Pol, A. N., E. Mocarskl, N. Saederup, J. Vieira, and T. J. Meier. 1999. Cytomegalovirus cell tropism, replication, and gene transfer in brain. J. Neurosci. 19:10948-10965.
39. Van Den Pol, A. N., J. Vieira, D. D. Spencer, and J. G. Santarelli. 2000. Mouse cytomegalovirus in developing brain tissue: analysis of 11 species with GFP-expressing recombinant virus. J. Comp. Neurol. 427:559-580.
40. Vieira, H. L., A. S. Belzacq, D. Haouzi, F. Bernassola, I. Cohen, E. Jacotot, K. F. Ferri, C. El Hamel, L. M. Bartle, G. Melino, C. Brenner, V. Goldmacher, and G. Kroemer. 2001. The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal. Oncogene 20:4305-4316.
41. Vink, C, E. Beuken, and C. A. Bruggeman. 2000. Complete DNA sequence of the rat cytomegalovirus genome. J. Virol. 74:7656-7665.
42. Wang, X., M. Messerle, R. Sapinoro, K. Santos, P. K. Hocknell, X. Jin, and S. Dewhurst. 2003. Murine cytomegalovirus abortively infects human dendritic cells, leading to expression and presentation of virally vectored genes. J. Virol. 77:7182-7192.
43. Wollmann, G., P. Tattersall, and A. N. van den Pol. 2005. Targeting human glioblastoma cells: comparison of nine viruses with oncolytic potential. J. Virol. 79:6005-6022.
44. Yu, D., H. M. Ellis, E. C. Lee, N. A. Jenkins, N. G. Copeland, and D. L. Court. 2000. An efficient recombination system for chromosome engineering in Escherichia coli. Proc. Natl. Acad. Sci. USA 97:5978-5983.